Navigation Links
Intradigm Licenses Key Next Generation RNA Interference (RNAi) Intellectual Property From University of Massachusetts Medical School
Date:4/9/2008

Company Continues to Fortify Position in Emerging RNAi Industry through Addition of Important and Novel Small Interfering RNA (siRNA) Structural IP

PALO ALTO, Calif., April 9, 2008 /PRNewswire/ -- Intradigm Corporation, a leading developer of targeted, systemic RNA interference (RNAi) therapeutics, today announced that it has licensed key intellectual property (IP) covering certain efficacy-enhancing structural elements of small interfering RNA (siRNA) from the University of Massachusetts Medical School. The licensed IP includes parameters for the structural modifications for next generation siRNAs including the "Zamore Design Rules" that significantly improve the potency and efficacy of RNAi therapeutics. This licensed technology allows Intradigm to incorporate novel siRNA sequences into the company's proprietary RNAi delivery systems to create potent and effective siRNA therapeutics. The company announced this licensing agreement today as part of its presentation at the Bio-Europe Spring 2008 conference in Madrid, Spain.

The technology licensed from the University of Massachusetts Medical School provides Intradigm with a strong IP position around structural features for a next generation of siRNA molecules. Additionally, Intradigm also possesses a strong IP position surrounding biodegradable polycationic polymers for the delivery of RNAi therapeutics which the company further strengthened through its recent licensing of complementary technology from the Massachusetts Institute of Technology (MIT). This newly licensed RNAi IP estate, combined with Intradigm's innovative delivery technology and proprietary siRNA sequences, positions the company as a leader in the RNAi therapeutic space.

"By licensing this important IP from the University of Massachusetts Medical School, which we believe to be the clear center of excellence for breakthrough siRNA academic research, Intradigm has taken another critical step toward its goal of establishing its
'/>"/>

SOURCE Intradigm Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco
2. MedImmune Licenses Reverse Genetics Technology to Novartis for Use in Influenza Vaccine Development and Production
3. Medinet Licenses MaxCyte Cell Loading Technology for Cancer Immunotherapy in Japan
4. Codexis Licenses New Drug Metabolite Profiling and Lead Diversification Technology From the California Institute of Technology
5. Southern Research Institute Licenses Anti-Cancer Drug Compound to Virium Pharmaceuticals
6. Protherics Licenses its CoVaccine HT Adjuvant to Nobilon for Influenza Vaccine Indications
7. HUYA Bioscience International Licenses Clinical Stage Anti-Arrhythmic Compound from the Shanghai Institute of Materia Medica
8. Syngenta Licenses Chromatin Gene Stacking Technology
9. Utrecht University Licenses MetaDrug From GeneGo for Drug Innovation
10. Prometheus Licenses COLAL-PRED(R) From Alizyme
11. Maxygen Licenses Dengue Vaccine Technology to sanofi pasteur

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)..., COPENHAGEN, Dec. 2 The world,...oIsoprene technology, a breakthrough alternative t... the manufacture of synthetic rubber with renewabl..., this week. One tire will be on display at a loun...International Airport throughout December 21, whil...
(Date:12/2/2009)..., LIBREVILLE, Gabon, December 2 /PRNewswire...ca: Everyone,s Problem and Heritage" , Co...ty, 2-3 June 2010 the,Gabonese Republic is hosting... on the issue of safeguarding biological resources...ernment and state leaders, ministers,scientific e...
(Date:12/2/2009)... , JERUSALEM, Israel, December 2 /PRNe...ty study evaluating the preclinical (animal study)...ch combines technology from Weill,Cornell Medical ...ntial to,treat inherited anemias such as Cooley,s ...ies of technologies to expand, ex vivo,population...
(Date:12/2/2009)... , NANJING, China, Dec. 2 /PRNewswire-Asia...e "Company") (NYSE: SCR ), a leading pharmaceuti...acturing, and marketing of branded,generic and pro... that 105 of,its drugs have been included in China...h was issued by China,s Ministry of Human Resource...
Breaking Biology Technology:The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 2The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 3Libreville International Conference 2-3 June 2010 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 3
...RainDance Technologies will,present a workshop on ...based solutions at the American Society of Human G... on Thursday, November 13th., Recent advances in ...,and dramatically reduced cost. However, even with...stems, sequencing thousands of human genomes,acros...
...RainDance Technologies will,present a workshop tit...fluidics" at the American Society of Human Genetic...ursday, November 13th., Recent advances in DNA se...ramatically reduced cost. However, even with the i... sequencing thousands of human genomes,across vari...
...rno Therapeutics,Inc. (OTC Bulletin Board: ARNI), ... on oncology therapeutics, today announced that Dr... will present at the Rodman & Renshaw 10th,Annual ... at 2:00 PM EST in,the Kennedy I room at the New Y... provide a company overview and update on the stat...
Other Biology Technology:RainDance Technologies to Present Workshop on Sequence Enrichment Using Innovative Microdroplet-Based Solutions at ASHG 2008 2RainDance Technologies to Present 'Sequence Enrichment Using Droplet-Based Microfluidics' Workshop at ASHG 2008 2Arno Therapeutics to Present at the Rodman & Renshaw 10th Annual Healthcare Conference 2
(Date:12/2/2009)... PHILADELPHIA Exposure to secondhand smoke for a ...increase the risk of breast cancer, even in women ...question of whether exposure to side-stream smoke ...s unresolved," said Peggy Reynolds, Ph.D., senior ...er Center,s Berkeley office. "While no single epid...
(Date:12/2/2009)...esearchers from the University of Georgia College ...ual discovery that could open new avenues for trea...astating single-celled protozoan parasite that com... whole-genome sequencing, researchers found that I...bacteria: Bacteroides, which are usually found fr...
(Date:12/2/2009)...t turns out that wearing a cap is good for you, at...rom the Johns Hopkins Engineering in Oncology Cent...p" of thread-like fibers holds the cell,s nucleus,...rstanding this cap,s influence on cell and nuclear...o the diagnosis and treatment of diseases such as ...
Breaking Biology News(10 mins):Exposure to secondhand cigarette smoke over a lifetime increased breast cancer risk later in life 2UGA researchers lead team in discovery involving devastating freshwater fish parasite, 'Ich' 2UGA researchers lead team in discovery involving devastating freshwater fish parasite, 'Ich' 3A cell's 'cap' of bundled fibers could yield clues to disease 2Advanced Life Sciences Announces Third Quarter 2009 Financial Results 6130 1Advanced Life Sciences Announces Third Quarter 2009 Financial Results 6130 2Advanced Life Sciences Announces Third Quarter 2009 Financial Results 6130 3Advanced Life Sciences Announces Third Quarter 2009 Financial Results 6130 4Advanced Life Sciences Announces Third Quarter 2009 Financial Results 6130 5Advanced Life Sciences Announces Third Quarter 2009 Financial Results 6130 6Advanced Life Sciences Announces Third Quarter 2009 Financial Results 6130 7Advanced Life Sciences Announces Third Quarter 2009 Financial Results 6130 8Advanced Life Sciences Announces Third Quarter 2009 Financial Results 6130 9Advanced Life Sciences Announces Third Quarter 2009 Financial Results 6130 10Reportlinker Adds Infections Ear Infections 6121 1Reportlinker Adds Infections Ear Infections 6121 2Reportlinker Adds Infections Ear Infections 6121 3Reportlinker Adds Infections Ear Infections 6121 4Reportlinker Adds Infections Ear Infections 6121 5Reportlinker Adds Infections Ear Infections 6121 6A pain in the neck 61060 1A pain in the neck 61060 2
...it fly gene is crucial for determining when juveni...formation initially proceeds. Understanding this p...ldren become surly teenagers. , When the DHR4 gene...rphosis ?maturation from an immature larva to a se...ion found to cause early maturation in fruit flies...
... of metabolomics. , The biotech field of genomics... genes to diseases. The subsequent study of protei...proteomics. , Now, a group of researchers at the U... State University will use $1.02 million in DOE st... processes that take place within the cells of pla...
...North Carolina Hospitals arrived in February sport... track record in helping to repair heart valves, r... arteries and perform gastric bypass operations fo...achine, the da Vinci Surgical System, manufactured...gynecological oncology program in the Southeast th...
Other Biology News:Scientists find a maturity gene in fly 2Scientists find a maturity gene in fly 3Scientists find a maturity gene in fly 4Making plant cells work like miniature factories 2Making plant cells work like miniature factories 3Surgical Robot 'Scrubs In' At UNC, May Be More Precise Than Conventional Surgery 2Surgical Robot 'Scrubs In' At UNC, May Be More Precise Than Conventional Surgery 3
Mouse Anti-Ia Antigen Monoclonal Antibody, Biotin Conjugated, Clone CIa from Abcam
Goat Anti-FBXO2 Polyclonal Antibody, Unconjugated from Abcam
Rabbit Anti-TAK1, phospho (Thr184 / Thr187) Monoclonal Antibody, Unconjugated, Clone 90C7 from Cell Signaling Technology
Mouse Anti-Factor V Heavy Chain Monoclonal Antibody, Unconjugated from GeneTex
Biology Products: